The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key? Arfon G. M. T. PowellPaul G. HorganJoanne Edwards Review 18 March 2012 Pages: 723 - 728
Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome Yujuan YangQingxia ZhangXiao Li Original Paper 15 January 2012 Pages: 729 - 737
Serum prolidase activity, oxidative stress, and nitric oxide levels in patients with bladder cancer Ilhan GecitMehmet AslanKadir Ceylan Original Article Open access 19 January 2012 Pages: 739 - 743
Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis Wei-Xiang QiLi-Na TangYang Yao Original Paper 19 January 2012 Pages: 745 - 751
Application of ex vivo 1H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases Hongchang GaoBaijun DongXiaokun Li Original Article 19 January 2012 Pages: 753 - 761
MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4 Jinhai LiYuanyuan GuoWenxi Wu Original Paper 22 January 2012 Pages: 763 - 774
Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2 Yin-Yan HeGui-Qiang DuXiao-Ping Wan Original Article 24 January 2012 Pages: 775 - 783
Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo Yong-Wei WangShuang-Jia WangBei Sun Original Paper 24 January 2012 Pages: 785 - 797
DNA methylation status of REIC/Dkk-3 gene in human malignancies Tatsuro HayashiHiroaki AsanoShinichiro Miyoshi Original Paper Open access 25 January 2012 Pages: 799 - 809
Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells Li-Qing DuXiao-Qing DuFei-Yue Fan Original Article 25 January 2012 Pages: 811 - 818
The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review Jin-tao QuMei WangXiao-jian Ye Original Paper 25 January 2012 Pages: 819 - 825
Effects of the inhibition of cytosolic phospholipase A2α in non-small cell lung cancer cells Shenbagamoorthy SundarrajSoundarapandian KannanPalani Gunasekaran Original Paper 25 January 2012 Pages: 827 - 835
Comparison of ER/PR and HER2 statuses in primary and paired liver metastatic sites of breast carcinoma in patients with or without treatment Jieqiong LiuHeran DengFengxi Su Original Paper 31 January 2012 Pages: 837 - 842
Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines Stefan HeindlEvelyn EggensteinBirgit Luber Original Paper 31 January 2012 Pages: 843 - 858
Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (−)-epigallocatechin gallate-treated cells Tatsuro WatanabeHiromi KuramochiMasami Suganuma Original Paper 02 February 2012 Pages: 859 - 866
Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers Ana CustodioAntonio J. López-FarréPedro Pérez-Segura Original Paper 07 February 2012 Pages: 867 - 875
A novel xenograft model with intrinsic vascularisation for growing undifferentiated pleomorphic sarcoma NOS in mice Daniel-Johannes TilkornAdrien DaigelerSammy Al-Benna Original Paper 07 February 2012 Pages: 877 - 884
Pseudolaric acid B inhibits inducible cyclooxygenase-2 expression via downregulation of the NF-κB pathway in HT-29 cells Li HouBo XuJing-Rong Cui Original Paper 08 February 2012 Pages: 885 - 896
Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation Enrico CappelliDonatella VecchioGuido Frosina Rapid Communication 07 April 2012 Pages: 897 - 899